Pharmaceutical

AbbVie and Umoja to develop new CAR-T therapies for cancer

AbbVie and Umoja Biopharma partnered for the development of in-situ CAR-T cell therapy candidates for oncology targets.

Jan 5, 2024 - 18:00
AbbVie and Umoja to develop new CAR-T therapies for cancer
AbbVie and Umoja Biopharma partnered for the development of in-situ CAR-T cell therapy candidates for oncology targets.
Read the original article

Tags:

Previous Article

MOMA Therapeutics and Roche sign cancer drug discovery deal

Next Article

Pharmaceutical Technology Excellence Awards 2023: KAI Conversations

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Lexicon partners Viatris for global expansion of sotagliflozin

Lexicon partners Viatris for global expansion of sotagl...

Oct 18, 2024

Vasomune wins FDA fast track designation for lung condition treatment

Vasomune wins FDA fast track designation for lung condi...

May 29, 2024

IMM-47 by ImmuneOnco Biopharmaceuticals (Shanghai) for ...

Oct 25, 2023